Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Arcutis Biotherapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 272
- +5 vs. Q1 2026
- Shares held
- 131.4M
- +936.9K (+0.7%) vs. Q1 2026
- Total value
- $3.45B
- +$372.0M (+12.1%) vs. Q1 2026
- New holders
- 41
- 95 more added
- Sold out
- 36
- 100 more reduced
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jupiter Asset Management Ltd | 202,515 | $5.31M | 0.03% | −14,740−6.8% | Reduced |
| Pictet Asset Management Holding SA | 200,275 | $5.35M | 0.01% | +62,163+45.0% | Added |
| Susquehanna International Group, LLP | 219,815 | $5.76M | 0.01% | +107,636+96.0% | Added |
| Swiss National Bank | 224,000 | $5.87M | 0.00% | +5,800+2.7% | Added |
| State of Wisconsin Investment Board | 230,905 | $6.05M | 0.01% | +130,003+128.8% | Added |
| UBS Asset Management Americas Inc | 231,186 | $6.06M | 0.00% | −5,985−2.5% | Reduced |
| Jump Financial, LLC | 235,471 | $6.17M | 0.06% | +185,904+375.1% | Added |
| MYDA Advisors LLC | 240,000 | $6.29M | 1.53% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 242,069 | $6.35M | 0.55% | +242,069 | New |
| Balyasny Asset Management LLC | 243,119 | $6.37M | 0.01% | +243,119 | New |
| Walleye Capital LLC | 260,033 | $6.82M | 0.03% | +209,573+415.3% | Added |
| Invesco Ltd. | 264,907 | $6.95M | 0.00% | +125,064+89.4% | Added |
| First Trust Advisors LP | 284,065 | $7.45M | 0.00% | −67,152−19.1% | Reduced |
| Healthcare of Ontario Pension Plan Trust Fund | 284,789 | $7.47M | 0.01% | −351,411−55.2% | Reduced |
| Peregrine Capital Management LLC | 291,447 | $7.64M | 0.25% | −14,825−4.8% | Reduced |
| Ameriprise Financial Inc | 295,997 | $7.76M | 0.00% | +194,323+191.1% | Added |
| FMR LLC | 305,969 | $8.02M | 0.00% | +27,233+9.8% | Added |
| Bank of New York Mellon Corp | 330,094 | $8.66M | 0.00% | +24,562+8.0% | Added |
| AQR Capital Management LLC | 330,324 | $8.66M | 0.00% | −137,929−29.5% | Reduced |
| Longaeva Partners L.P. | 344,796 | $9.04M | 0.26% | +344,796 | New |
| Qube Research & Technologies Ltd | 361,662 | $9.48M | 0.01% | −362,405−50.1% | Reduced |
| Point72 Asset Management, L.P. | 362,449 | $9.50M | 0.01% | −228,428−38.7% | Reduced |
| Patient Square Capital LP | 370,000 | $9.70M | 1.50% | −30,645−7.6% | Reduced |
| Deutsche Bank AG | 382,682 | $10.0M | 0.00% | −7,165−1.8% | Reduced |
| Norges Bank | 392,300 | $10.3M | 0.00% | +392,300 | New |
| Privium Fund Management B.V. | 399,367 | $10.5M | 1.92% | +78,395+24.4% | Added |
| Marshall Wace, LLP | 446,866 | $11.7M | 0.01% | −1,984,912−81.6% | Reduced |
| Adage Capital Partners GP, L.L.C. | 466,000 | $12.2M | 0.02% | +100,000+27.3% | Added |
| Nearwater Capital Markets, Ltd | 486,700 | $12.8M | 0.22% | −120,600−19.9% | Reduced |
| Capitolis Liquid Global Markets LLC | 500,000 | $13.1M | 0.06% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 537,747 | $14.1M | 0.03% | −565,743−51.3% | Reduced |
| BNP Paribas Arbitrage, SA | 547,278 | $14.3M | 0.01% | −264,868−32.6% | Reduced |
| Millennium Management LLC | 564,072 | $14.8M | 0.01% | +514,739+1,043.4% | Added |
| Fishman Jay A Ltd | 595,005 | $15.6M | 1.24% | +28,275+5.0% | Added |
| Two Sigma Investments, LP | 663,877 | $17.4M | 0.01% | +429,570+183.3% | Added |
| Manufacturers Life Insurance Company, The | 811,752 | $21.3M | 0.02% | +307,896+61.1% | Added |
| Vanguard Fiduciary Trust Co | 815,138 | $21.4M | 0.00% | +43,374+5.6% | Added |
| Nuveen, LLC | 834,261 | $21.9M | 0.01% | −67,873−7.5% | Reduced |
| Driehaus Capital Management LLC | 878,426 | $23.0M | 0.13% | −1,347,603−60.5% | Reduced |
| Candriam Luxembourg S.C.A. | 949,839 | $24.9M | 0.11% | −136,812−12.6% | Reduced |
| Ensign Peak Advisors, Inc | 974,534 | $25.6M | 0.04% | −269,853−21.7% | Reduced |
| Charles Schwab Investment Management Inc | 1,050,934 | $27.6M | 0.00% | +38,379+3.8% | Added |
| Northern Trust Corp | 1,058,575 | $27.8M | 0.00% | +82,063+8.4% | Added |
| Jones Hill Capital LP | 1,089,701 | $28.6M | 6.07% | +1,089,701 | New |
| Standard Life Aberdeen plc | 1,098,411 | $28.8M | 0.04% | +453,345+70.3% | Added |
| Perpetual Ltd | 1,109,657 | $29.1M | 0.42% | +200,111+22.0% | Added |
| Federated Hermes, Inc. | 1,124,629 | $29.5M | 0.04% | +47,362+4.4% | Added |
| Citadel Advisors LLC | 1,160,014 | $30.4M | 0.02% | +1,144,408+7,333.1% | Added |
| Bamco Inc | 1,253,120 | $32.9M | 0.05% | +180,931+16.9% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,265,283 | $33.2M | 10.78% | −90,609−6.7% | Reduced |
| GW&K Investment Management, LLC | 1,288,018 | $33.8M | 0.26% | +299,631+30.3% | Added |
| Gilder Gagnon Howe & Co LLC | 1,313,211 | $34.4M | 0.36% | −2,990,799−69.5% | Reduced |
| Oberweis Asset Management Inc | 1,372,941 | $36.0M | 0.74% | +7,000+0.5% | Added |
| Jupiter Topco LLC | 1,410,435 | $37.0M | 0.02% | +1,410,435 | New |
| Goldman Sachs Group Inc | 1,668,367 | $43.7M | 0.00% | +65,354+4.1% | Added |
| American Century Companies Inc | 1,925,031 | $50.5M | 0.02% | +461,803+31.6% | Added |
| Franklin Resources Inc | 1,930,982 | $50.6M | 0.01% | −366,961−16.0% | Reduced |
| OrbiMed Advisors LLC | 2,042,000 | $53.5M | 1.01% | +2,042,000 | New |
| Vanguard Portfolio Management LLC | 2,429,005 | $63.7M | 0.00% | +474,320+24.3% | Added |
| Geode Capital Management, LLC | 2,982,446 | $78.2M | 0.00% | −62,860−2.1% | Reduced |
| Bank of America Corp | 2,987,431 | $78.3M | 0.01% | +766,142+34.5% | Added |
| UBS Group AG | 3,333,015 | $87.4M | 0.01% | +3,791+0.1% | Added |
| D. E. Shaw & Co., Inc. | 3,949,609 | $103.6M | 0.06% | +1,453,387+58.2% | Added |
| Jennison Associates LLC | 4,219,058 | $110.6M | 0.07% | −761,712−15.3% | Reduced |
| Morgan Stanley | 4,451,014 | $116.7M | 0.01% | +232,083+5.5% | Added |
| Vanguard Capital Management LLC | 4,988,756 | $130.8M | 0.00% | +117,220+2.4% | Added |
| State Street Corp | 5,822,840 | $152.7M | 0.00% | −473,357−7.5% | Reduced |
| Polar Capital Holdings Plc | 6,606,945 | $173.2M | 0.49% | +940,005+16.6% | Added |
| Rubric Capital Management LP | 8,271,577 | $216.9M | 1.99% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 9,874,511 | $258.9M | 5.64% | 00.0% | Unchanged |
| BlackRock, Inc. | 10,545,466 | $276.5M | 0.00% | +1,345,055+14.6% | Added |
| Suvretta Capital Management, LLC | 12,437,000 | $326.1M | 6.85% | +110,000+0.9% | Added |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −733,966−100.0% | Sold out |
| M&G Plc | 0 | $0 | 0.00% | −469,082−100.0% | Sold out |
| Zevenbergen Capital Investments LLC | 0 | $0 | 0.00% | −357,490−100.0% | Sold out |
| Penn Capital Management Co Inc | 0 | $0 | 0.00% | −333,130−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −188,220−100.0% | Sold out |
| Nordea Investment Management AB | 0 | $0 | 0.00% | −192,920−100.0% | Sold out |
| Jackson Creek Investment Advisors LLC | 0 | $0 | 0.00% | −68,646−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −65,977−100.0% | Sold out |
| Invst, LLC | 0 | $0 | 0.00% | −35,205−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −31,544−100.0% | Sold out |
| D.A. Davidson & Co. | 0 | $0 | 0.00% | −27,458−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| LVW Advisors, LLC | 0 | $0 | 0.00% | −23,091−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −22,943−100.0% | Sold out |
| Elevated Financial Group LLC | 0 | $0 | 0.00% | −20,543−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,050−100.0% | Sold out |
| Merit Financial Group, LLC | 0 | $0 | 0.00% | −18,852−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −17,042−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −16,181−100.0% | Sold out |
| Independent Financial Group, LLC | 0 | $0 | 0.00% | −8,906−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −4,026−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,689−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,550−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −921−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Blue Bell Private Wealth Management, LLC | 0 | $0 | 0.00% | −369−100.0% | Sold out |
| Rachor Investment Advisory Services, LLC | 0 | $0 | 0.00% | −269−100.0% | Sold out |
| Prestige Wealth Management Group LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |